Literature DB >> 14760

Prazosin, a selective antagonist of post-synaptic alpha-adrenoceptors [proceedings].

D Cambridge, M J Davey, R Massingham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 14760      PMCID： PMC1667965     

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN： 0007-1188            Impact factor:   8.739


× No keyword cloud information.
  5 in total

1.  Relative pre- and postsynaptic potencies of alpha-adrenoceptor agonists in the rabbit pulmonary artery.

Authors:  K Starke; T Endo; H D Taube
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1975       Impact factor: 3.000

Review 2.  Presynaptic regulation of catecholamine release.

Authors:  S Z Langer
Journal:  Biochem Pharmacol       Date:  1974-07-01       Impact factor: 5.858

3.  The release of H3-norepinephrine in arterial strips studied by the technique of superfusion and transmural stimulation.

Authors:  C Su; J A Bevan
Journal:  J Pharmacol Exp Ther       Date:  1970-03       Impact factor: 4.030

Review 4.  Role of transmitter uptake mechanisms in synaptic neurotransmission.

Authors:  L L Iversen
Journal:  Br J Pharmacol       Date:  1971-04       Impact factor: 8.739

5.  A comparsion of the effects of prazosin and hydrallazine on blood pressure, heart rate and plasma renin activity in conscious renal hypertensive dogs.

Authors:  R Massingham; M L Hayden
Journal:  Eur J Pharmacol       Date:  1975-01       Impact factor: 4.432
  5 in total
  97 in total

1.  Effects of arotinolol on exercise capacity and humoral factors during exercise in normal subjects.

Authors:  T Mori; K Handa; Y Terao; H Tanaka; A Kiyonaga; M Shindo; A Matsunaga; J Sasaki; K Arakawa
Journal:  Cardiovasc Drugs Ther       Date:  1992-08       Impact factor: 3.727

Review 2.  Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1977-09       Impact factor: 9.546

3.  Involvement of presynaptic alpha-adrenoceptors in the cardiovascular and sedative effects of FLA-136.

Authors:  P B Timmermans; E Lam; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1979-03       Impact factor: 3.000

4.  Hyperpolarizing 'alpha 2'-adrenoceptors in rat sympathetic ganglia.

Authors:  D A Brown; M P Caulfield
Journal:  Br J Pharmacol       Date:  1979-03       Impact factor: 8.739

5.  Studies with abanoquil (UK-52,046) a novel quinoline alpha 1-adrenoceptor antagonist: II. Duration of action, pharmacokinetics and concentration-effect relationships in normotensive subjects.

Authors:  R F Schafers; H L Elliott; P A Meredith; S H Miller; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

6.  Prazosin depression of baroreflex function in hypertensive man.

Authors:  E H Sasso; D T O'Connor
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Mechanism of action of dopamine on the guinea-pig gastro-oesophageal junction in vitro.

Authors:  B Cox; C Ennis
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

8.  The influence of hormonal and neuronal factors on rat heart adrenoceptors.

Authors:  G Kunos; L Mucci; S O'Regan
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

9.  A study of alpha 1-adrenoceptors in rat renal cortex: comparison of [3H]-prazosin binding with the alpha 1-adrenoceptor modulating gluconeogenesis under physiological conditions.

Authors:  G A McPherson; R J Summers
Journal:  Br J Pharmacol       Date:  1982-09       Impact factor: 8.739

10.  A pharmacodynamic and pharmacokinetic assessment of a new alpha-adrenoceptor antagonist, doxazosin (UK33274) in normotensive subjects.

Authors:  H L Elliott; P A Meredith; D J Sumner; K McLean; J L Reid
Journal:  Br J Clin Pharmacol       Date:  1982-05       Impact factor: 4.335
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.